Nanopore sequencing using ratiometric impedance

USRE47067E · US · E1

Patent metadata
FieldValue
Publication numberUS-RE47067-E
Application numberUS-201514811631-A
CountryUS
Kind codeE1
Filing dateJul 28, 2015
Priority dateApr 9, 2010
Publication dateOct 2, 2018
Grant dateOct 2, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to devices and methods for nanopore sequencing. The invention includes arrays of nanopores having incorporated electronic circuits, for example, in CMOS. The invention includes devices having sample and reference pores connecting sample, measurement and reference chambers, wherein potential measurements in each chamber is used to provide an accurate determination of current through a sample nanopore, improving nanopore sequencing.

First claim

Opening claim text (preview).

We claim: 1. A device for determining the identity of a single molecule passing through a nanopore comprising: three fluidic regions comprising i) a sample fluidic region, ii) a measurement fluidic region, and iii) a reference fluidic region; a substrate comprising a measurement electrode positioned to sense the potential of the measurement fluidic region; a first aperture comprising a nanopore through which one or more sample molecules are transported, the first aperture connecting the sample fluidic region and the measurement fluidic region; a second aperture connecting the measurement fluidic region with the reference fluidic region; and a pair of drive electrodes, whereby a potential drop across the drive electrodes drives a sample molecule into the nanopore of the first aperture from the sample fluidic region, and wherein the device further comprises a sample electrode positioned to sense the potential of the sample fluidic region and a reference electrode positioned to sense the potential of the reference fluidic region, wherein the presence of the sample molecule in the nanopore of the first aperture is detected using the potential measurements at the sample electrode, the measurement electrode, and the reference electrode. 2. The device of claim 1 wherein the sample electrode comprises the gate of a first transistor element positioned to sense the potential of the sample fluidic region, the measurement electrode comprises the gate of a second transistor element positioned to sense the potential of the measurement fluidic region, and the reference electrode comprises the gate of a third transistor element positioned to sense the potential of the reference fluidic region. 3. The device of claim 2 wherein one or more of the first, second, and third transistor elements is a naked gate transistor having no metal electrode. 4. The device of claim 3 wherein the gate of the one or more naked gate transistors has a thin insulating film between the gate and the fluidic region in which the transistor is positioned. 5. The device of claim 2 wherein the device is fabricated in substrate is a semiconductor substrate by etching a well into the substrate, forming a semiconductor lid over the well to form a chamber, fabricating transistors onto the substrate, and etching holes through the lid into the chamber for sample and reference nanopores. 6. The device of claim 5 wherein the substrate comprises silicon, silicon on insulator (SOI), or silicon on sapphire. 7. The device of claim 2 wherein the device comprises sample, reference, and measurement electrodes comprise a vertical IGFET. 8. The device of claim 7 wherein the vertical IGFET is produced by forming substrate is a P-doped substrate comprising an N-doped well in a P-doped substrate, filling the N-doped well filled with a P-doped semiconductor layer, forming wherein the device further comprises (i) a hole that extends through the P-doped semiconductor layer, the N-doped well, and the P-doped substrate, and fabricating (ii) electrodes onto on the top surface of the P-doped semiconductor layer and the P-doped substrate such that these become the source and drain of the IGFET. 9. The device of claim 2 5 wherein the transistors are formed present on the top of a the semiconductor substrate, and wherein the device comprises a fluidic structure is produced on top of the semiconductor substrate, the fluidic structure establishing sample, measurement and reference the three fluidic regions having a sample nanopore between the sample and measurement fluidic regions, and a reference nanopore between the measurement and reference regions, the first aperture, and the second aperture. 10. The device of claim 1 wherein the sample molecule comprises a single stranded nucleic acid molecule. 11. The device of claim 1 wherein the sample molecule comprises a nucleotide analog having a charge blockade label. 12. The device of claim 1 wherein a sample potential V1, a measurement potential V2, and a reference potential V3 are measured, and whereby the presence of a sample molecule within the nanopore of the first aperture is detected using the value of (V 1 −V 2 )/(V 2 −V 3 ). 13. An analytical device comprising a plurality of devices of claim 1 sharing a common substrate. 14. The analytical device of claim 13 wherein the sample fluidic regions of the plurality of devices are simultaneously accessible to a fluidic sample for loading the sample fluidically connected. 15. An analytical device comprising 1,000 to 100,000 devices of claim 1 . 16. The device of claim 1 further comprising a polymerase enzyme attached proximal to the nanopore of the first aperture whereby when a nucleotide analog comprising a phosphate linked blockade label is associated with the polymerase enzyme, the blockade label at least partially blocks the pore such that the association between the nucleotide analog and the polymerase enzyme is detected. 17. A nucleic acid sequencing analytical device comprising a plurality of devices on a single substrate, each device comprising: three fluidic regions comprising i) a sample fluidic region, ii) a measurement fluidic region, and iii) a reference fluidic region; a measurement electrode positioned to sense the potential of the measurement fluidic region; a first aperture comprising a nanopore through which one or more sample molecules are transported, the first aperture connecting the sample fluidic region and the measurement fluidic region; a second aperture connecting the measurement fluidic region with the reference fluidic region; a polymerase enzyme-template nucleic acid complex attached proximal to the first aperture; a sequencing reaction mixture in the sample fluidic region comprising a plurality of types of labeled nucleotide analogs, each having a different type of blockade label; and a pair of drive electrodes, whereby a potential drop across the drive electrodes drives a blockade label into the nanopore of the first aperture from the sample fluidic region, and wherein the device further comprises a sample electrode positioned to sense the potential of the sample fluidic region and a reference electrode positioned to sense the potential of the reference fluidic region, wherein the presence of the blockade in the nanopore of the first aperture is detected using the potential measurements at the sample electrode, the measurement electrode, and the reference electrode. 18. The analytical device of claim 17 wherein the plurality of devices comprises greater than 1000 devices. 19. A method of fabricating the device of claim 2, wherein the substrate is a semiconductor substrate, the method comprising: etching a well into the semiconductor substrate; forming a semiconductor lid over the well to form a chamber; fabricating transistors onto the substrate; and etching holes through the lid into the chamber for sample and reference nanopores. 20. A method of fabricating the device of claim 2, wherein the substrate is a semiconductor substrate, the method comprising: forming the transistors on the top of the semiconductor substrate; producing a fluidic structure on top of the semiconductor substrate establishing the sample, measurement and reference fluidic regions; wherein the fluidic structure comprises the first and second aperture. 21. A method of fabricating the device of claim 7, wherein the substrate is a P-doped substrate, the method comprising: forming an N-doped well in the P-doped substrate; filling the N-doped well with

Assignees

Inventors

Classifications

  • Microapparatus (sample containers with integrated microfluidic structures B01L3/5027) · CPC title

  • using electrophoresis · CPC title

  • Investigating individual macromolecules, e.g. by translocation through nanopores (Coulter counters in general G01N15/12; fabrication methods for nanoscale apertures B81B1/00; sequencing of nucleic acids C12Q1/68) · CPC title

  • C12Q1/6869Primary

    Methods for sequencing · CPC title

  • involving nucleic acids · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent USRE47067E cover?
The invention relates to devices and methods for nanopore sequencing. The invention includes arrays of nanopores having incorporated electronic circuits, for example, in CMOS. The invention includes devices having sample and reference pores connecting sample, measurement and reference chambers, wherein potential measurements in each chamber is used to provide an accurate determination of curren…
Who is the assignee on this patent?
Pacific Biosciences California Inc
What technology area does this patent fall under?
Primary CPC classification G01N33/48721. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Oct 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (E1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).